Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update - PubMed (original) (raw)
Review
. 2019 Aug 13;140(7):e294-e324.
doi: 10.1161/CIR.0000000000000691. Epub 2019 Jun 6.
Michael M Givertz, David Aguilar, Larry A Allen, Michael Chan, Akshay S Desai, Anita Deswal, Victoria Vaughan Dickson, Mikhail N Kosiborod, Carolyn L Lekavich, Rozalina G McCoy, Robert J Mentz, Ileana L Piña; American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and the Heart Failure Society of America
- PMID: 31167558
- DOI: 10.1161/CIR.0000000000000691
Free article
Review
Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update
Shannon M Dunlay et al. Circulation. 2019.
Free article
Erratum in
- Correction to: Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America.
[No authors listed] [No authors listed] Circulation. 2019 Sep 17;140(12):e692. doi: 10.1161/CIR.0000000000000735. Epub 2019 Sep 16. Circulation. 2019. PMID: 31525098 No abstract available.
Abstract
Type 2 diabetes mellitus is a risk factor for incident heart failure and increases the risk of morbidity and mortality in patients with established disease. Secular trends in the prevalence of diabetes mellitus and heart failure forecast a growing burden of disease and underscore the need for effective therapeutic strategies. Recent clinical trials have demonstrated the shared pathophysiology between diabetes mellitus and heart failure, the synergistic effect of managing both conditions, and the potential for diabetes mellitus therapies to modulate the risk of heart failure outcomes. This scientific statement on diabetes mellitus and heart failure summarizes the epidemiology, pathophysiology, and impact of diabetes mellitus and its control on outcomes in heart failure; reviews the approach to pharmacological therapy and lifestyle modification in patients with diabetes mellitus and heart failure; highlights the value of multidisciplinary interventions to improve clinical outcomes in this population; and outlines priorities for future research.
Keywords: AHA Scientific Statement; diabetes mellitus, type 2; drug therapy; heart failure; lifestyle; risk factors.
Similar articles
- Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America.
Dunlay SM, Givertz MM, Aguilar D, Allen LA, Chan M, Desai AS, Deswal A, Dickson VV, Kosiborod MN, Lekavich CL, McCoy RG, Mentz RJ, PiÑa IL; American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Heart Failure Society of America. Dunlay SM, et al. J Card Fail. 2019 Aug;25(8):584-619. doi: 10.1016/j.cardfail.2019.05.007. Epub 2019 Jun 5. J Card Fail. 2019. PMID: 31174952 Review. - 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, Drazner MH, Filippatos GS, Fonarow GC, Givertz MM, Hollenberg SM, Lindenfeld J, Masoudi FA, McBride PE, Peterson PN, Stevenson LW, Westlake C. Yancy CW, et al. J Card Fail. 2017 Aug;23(8):628-651. doi: 10.1016/j.cardfail.2017.04.014. Epub 2017 Apr 28. J Card Fail. 2017. PMID: 28461259 Review. No abstract available. - 2017 ACC/AHA/HFSA/ISHLT/ACP Advanced Training Statement on Advanced Heart Failure and Transplant Cardiology (Revision of the ACCF/AHA/ACP/HFSA/ISHLT 2010 Clinical Competence Statement on Management of Patients With Advanced Heart Failure and Cardiac Transplant): A Report of the ACC Competency Management Committee.
Jessup M, Drazner MH, Book W, Cleveland JC Jr, Dauber I, Farkas S, Ginwalla M, Katz JN, Kirkwood P, Kittleson MM, Marine JE, Mather P, Morris AA, Polk DM, Sakr A, Schlendorf KH, Vorovich EE. Jessup M, et al. J Card Fail. 2017 Jun;23(6):492-511. doi: 10.1016/j.cardfail.2017.04.004. Epub 2017 Apr 25. J Card Fail. 2017. PMID: 28454730 No abstract available. - 2016 ESC and ACC/AHA/HFSA heart failure guideline update - what is new and why is it important?
Jessup M, Marwick TH, Ponikowski P, Voors AA, Yancy CW. Jessup M, et al. Nat Rev Cardiol. 2016 Sep 14;13(10):623-8. doi: 10.1038/nrcardio.2016.134. Nat Rev Cardiol. 2016. PMID: 27625120 Review. - 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.
WRITING COMMITTEE MEMBERS; Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, Drazner MH, Filippatos G, Fonarow GC, Givertz MM, Hollenberg SM, Lindenfeld J, Masoudi FA, McBride PE, Peterson PN, Stevenson LW, Westlake C. WRITING COMMITTEE MEMBERS, et al. Circulation. 2016 Sep 27;134(13):e282-93. doi: 10.1161/CIR.0000000000000435. Epub 2016 May 20. Circulation. 2016. PMID: 27208050 No abstract available.
Cited by
- Glucagon-like Peptide-1 Receptor Agonists in the Context of Pathophysiology of Diverse Heart Failure with Preserved Ejection Fraction Phenotypes: Potential Benefits and Mechanisms of Action.
Bykova A, Serova M, Chashkina M, Kosharnaya R, Salpagarova Z, Andreev D, Giverts I. Bykova A, et al. Card Fail Rev. 2024 Oct 16;10:e14. doi: 10.15420/cfr.2024.06. eCollection 2024. Card Fail Rev. 2024. PMID: 39507374 Free PMC article. Review. - Leveraging calcium score CT radiomics for heart failure risk prediction.
Singh P, Hoori A, Freeze J, Hu T, Tashtish N, Gilkeson R, Li S, Rajagopalan S, Wilson DL, Al-Kindi S. Singh P, et al. Sci Rep. 2024 Nov 6;14(1):26898. doi: 10.1038/s41598-024-77269-x. Sci Rep. 2024. PMID: 39505933 Free PMC article. - The Role of Natriuretic Peptides in the Management of Heart Failure with a Focus on the Patient with Diabetes.
Vergani M, Cannistraci R, Perseghin G, Ciardullo S. Vergani M, et al. J Clin Med. 2024 Oct 18;13(20):6225. doi: 10.3390/jcm13206225. J Clin Med. 2024. PMID: 39458174 Free PMC article. Review. - Emerging Role of Natriuretic Peptides in Diabetes Care: A Brief Review of Pertinent Recent Literature.
Tiwari D, Aw TC. Tiwari D, et al. Diagnostics (Basel). 2024 Oct 9;14(19):2251. doi: 10.3390/diagnostics14192251. Diagnostics (Basel). 2024. PMID: 39410655 Free PMC article. Review. - Novel Biomarkers of Grade I Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Patients with Metabolic-Dysfunction-Associated Steatotic Liver Disease.
Braha A, Timar B, Ivan V, Balica MM, Dăniluc L, Timar R. Braha A, et al. J Clin Med. 2024 Oct 2;13(19):5901. doi: 10.3390/jcm13195901. J Clin Med. 2024. PMID: 39407960 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical